InfuSystem today announced that it entered a national distribution agreement with Solo-Dex for its continuous nerve block catheters.
Solo-Dex’s catheter over the needle technology allows anesthesiologists to place facile continuous peripheral block catheters in two to three minutes. It can be used in common procedures such as shoulder repair, hip and knee replacement and in general surgical procedures. The company designed the technology to remain in place to introduce the type, quantity and volume of acute pain management medication continuously.
“InfuSystem is pleased to join with Solo-Dex in bringing innovation to the acute pain management market. Solo-Dex will bring technology to our customers that makes it easier for the anesthesiologist to place nerve block catheters safely and effectively. As a result, we believe more patients will have the opportunity to receive our services and recover quickly without requiring the use of oral opioid pain management,” InfuSystem CEO Richard Dilorio said in a news release.
“Solo-Dex Facile, coupled with InfuSystem’s InfuBlock Pain Management Therapy program and follow-up services, are now collaborating to bring cost-effective, easy-to-use continuous regional acute pain management to a market which is estimated to be 10 times larger than the current nerve catheter market,” Solo-Dex CEO Steve Eror said.
